Incyte axes JAK1 inhibitor from pipeline 2 years after PhIII flop crushed hopes
04 Aug 2022 //
ENDPTS
Incyte sinks as itacitinib fails pivotal test in acute GVHD
04 Jan 2020 //
FIERCE BIOTECH
Incyte takes a beating as a key PhIII study flops in latest painful setback
02 Jan 2020 //
BUSINESSWIRE
Incyte Announces First Patient Treated in Phase 3 Clinical Trial of Itacitinib
22 Jan 2019 //
BUSINESSWIRE